Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies. - Wikidata - wikimedia - TriplyDB

Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.

Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.

http://www.wikidata.org/entity/Q37619784

about

Inhibition of Orai1-mediated Ca2+ entry enhances chemosensitivity of HepG2 hepatocarcinoma cells to 5-fluorouracil.Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.

P2860

Q37747427-9E8C8993-8C46-40C0-B8D9-1E029856EA4B Q52664561-7FD2DFFB-C2E3-4315-887F-D4CA7B70A304

P2860

Simultaneous inhibition of Vps34 kinase would enhance PI3Kδ inhibitor cytotoxicity in the B-cell malignancies.

http://www.wikidata.org/entity/Q37619784

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@en

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@nl

type

label

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@en

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@nl

prefLabel

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@en

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@nl

P1433

Q37619784-FCD812CD-5556-40FC-9809-351067DDAEA2

P1476

Q37619784-CBEA0700-F918-47B6-934B-804A068183C0

P2093

Q37619784-0061E9B7-37D3-4104-880B-41F607B56C75

Q37619784-0DB035F0-1C3F-4813-AE8B-96E677E68481

Q37619784-2B690D15-A789-42FC-A54F-688FFBEB671A

Q37619784-2CDC7C29-6675-4BAF-9EE2-547060944734

Q37619784-2F3F13E6-CAB1-42C9-95C1-87E0DB5E2786

Q37619784-3C0CE164-0557-4943-8298-D7D0963A40FE

Q37619784-44D62C14-E8EF-4661-9AB5-E0FA17163CDD

Q37619784-4AA81AB3-CC51-4CA3-A41B-48469453E989

Q37619784-588269C4-A101-4E6F-8FC7-5EB1694ECC64

Q37619784-5DAFA5C1-D1B7-4B81-9D7D-2466E5FA7B61

P2860

Q37619784-01E6487E-A55B-4866-8D43-1AB622002C7F

Q37619784-050C6E3B-CEAE-4805-9BAC-5563605EDF23

Q37619784-27E2AC59-7B4F-415D-8F42-787415583408

Q37619784-3127108E-47AE-455A-AA88-E042D48E0BD8

Q37619784-35FF9356-B37C-4D72-8561-03180C2191D6

Q37619784-3AD1F6ED-DF89-40A7-B26A-AB44C537ACE5

Q37619784-3B2585A8-509D-4BC7-AAA1-B1E61D6D5019

Q37619784-601493EF-C895-4FEC-90C1-9595198AEDFE

Q37619784-6CE81378-FEC8-491A-BAF6-E5F1FF810847

Q37619784-8C95F884-BE3E-4779-BB18-5266CBBFFF55

P304

Q37619784-B7CB56C0-0315-4A1C-8E0D-66CCD4AC947E

P31

Q37619784-8148B667-DE63-4CC3-9969-8E2FA0A5C92F

P356

Q37619784-E57169AE-E40F-4A02-9373-84B5F3192CCE

P407

Q37619784-0D564E15-4687-4734-A5E4-0EB54034AC8C

P433

Q37619784-2B50BD84-7DD8-499C-A49E-2E10AF678B31

P478

Q37619784-96FA8732-DCF5-4723-B49B-D0F8E4239F0E

P50

Q37619784-37943073-B0BB-46F9-9310-8431B68025EE

P577

Q37619784-B79D36BB-E907-40D0-859B-5D2C6D6E5630

P698

Q37619784-DCADF3BB-7CE2-436C-9A28-3E775D76FF41

P921

Q37619784-11340C60-B982-4E76-A68A-D75ECEE9FFC3

P932

Q37619784-997B3D15-548A-4424-B865-8373D09AEAA1

P356

ONCOTARGET.10650

P1433

P1476

Simultaneous inhibition of Vps ...... ty in the B-cell malignancies.

@en

P2093

Aoli Wang

http://www.w3.org/2001/XMLSchema#string

Beilei Wang

http://www.w3.org/2001/XMLSchema#string

Ellen L Weisberg

http://www.w3.org/2001/XMLSchema#string

Feiyang Liu

http://www.w3.org/2001/XMLSchema#string

Fengming Zou

http://www.w3.org/2001/XMLSchema#string

Hong Wu

http://www.w3.org/2001/XMLSchema#string

Ilene A Galinsky

http://www.w3.org/2001/XMLSchema#string

James D Griffin

http://www.w3.org/2001/XMLSchema#string

Jennifer R Brown

http://www.w3.org/2001/XMLSchema#string

Jing Liu

http://www.w3.org/2001/XMLSchema#string

P2860

p110delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes

Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

Differential regulatory functions of three classes of phosphatidylinositol and phosphoinositide 3-kinases in autophagy

Autophagosome formation from membrane compartments enriched in phosphatidylinositol 3-phosphate and dynamically connected to the endoplasmic reticulum.

PI3K and cancer: lessons, challenges and opportunities

Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase

Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia.

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol.

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic.

P304

53515-53525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.10650

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27447747

http://www.w3.org/2001/XMLSchema#string

P921

P932

5288202

http://www.w3.org/2001/XMLSchema#string